- +359 878 17 2024
- Mon - Fri: 9:00 - 18:30
InQu® is the cell-friendly biosynthetic™ bone graft with proven clinical efficacy leading to faster bone fusion.
about the product
Clinically proven fusion rates of 94%, outperforming fusion rates for ICBG at 12 months.
Integrated PLGA and hyaluronic acid creates a cell-friendly microenvironment, binding MSCs and growth factors.
Demonstrated robust fusion, even in challenging high-risk patients.
Shorter time to fusion vs. traditional synthetic bone grafts AND superior overall fusion rates at 12 months: 93% vs. 68%
InQu offers a cost-effective, on-label solution for fusion throughout the spine.
A cohesive, moldable putty providing ease-of-use for a variety of applications.
InQu partners with the body’s natural processes to form bone in a shorter period of time without inciting an immune response. In contrast, traditional synthetics rely on inflammation and recruitment of specialized cells to digest the mineral scaffold before new bone formation can begin.
WhatsApp us
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
1Besides the Spraypen®, the Vivostat® system offers different types of applicators, e.g. the Endoscopic Applicator. For a full list of application devices click here